Variable | Insulin group | Metformin group | GLP-1 drug group | P |
---|---|---|---|---|
Total patients (n) | 54 | 54 | 42 | Â |
Age (years) | 56.5 ± 9.4 | 55.5 ± 8.2 | 56.8 ± 8.7 | 0.726 |
HbA1c (%) | 7.0 ± 0.5 | 6.9 ± 0.5 | 7.0 ± 0.5 | 0.714 |
Sex | ||||
Male/female | 40/14 | 46/8 | 33/9 | 0.358 |
Total implants (n) | 101 | 121 | 86 | Â |
Length (mm) | 10.5 ± 1.5 | 10.8 ± 1.7 | 10.8 ± 1.9 | 0.392 |
Arch | ||||
Maxillary/mandibular | 61/40 | 72/49 | 44/42 | 0.376 |
Location | ||||
Anterior/posterior | 22/79 | 34/87 | 25/61 | 0.448 |
Position of fixture | ||||
Submerged /non-submerged | 54/47 | 55/66 | 61/25 | 0.001** |
Major surface treatment | ||||
SLA/Anodic oxidation | 54/47 | 73/4 | 39/47 | 0.103 |
Restoration type | ||||
Single/multiple ceramic restoration | 39/62 | 38/83 | 35/51 | 0.332 |